Calprotectin is raised in endogenous posterior uveitis

References

• Forrester J V. Duke-Elder Lecture: new concepts on the role of autoimmunity in the pathogenesis of uveiti. Eye 1992; 6: 433–446
   PubMed Web of Science ®Google Scholar
• Dick A D, Cheng Y F, Purdie A T, Liversidge J, Forrester J V. Immunocytochemical analysis of blood lymphocytes in uveiti. Eye 1992; 6: 643–647
   PubMed Web of Science ®Google Scholar
• Dick A D. Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?. Br J Ophthalmol 1995; 79: 81–88
   PubMed Web of Science ®Google Scholar
• Klok A M, Geertzen R, Rothova A, Baarsma G S, Kijlstra A. Anticardiolipin antibodies in uveitis. Curr Eye Res 1992; 11(Suppl)209–213
   PubMedGoogle Scholar
• Brandtzaeg P, Dale I, Gabrielsen T O. The leucocyte protein L1 (calprotectin): usefulness as an immunohistochemical marker antigen and putative biological functio. Histopathology 1992; 21: 191–196
   PubMed Web of Science ®Google Scholar
• Fagerhol M K, Andersson K B, Naels-Andresen C-F, Brandtzaeg P, Dale I. Calprotectin (the L1 leukocyte protein). Stimulus response coupling: The role of intracellular calcium binding proteins, V L Smith, J R. Dedman. CRC Press, Boca Raton 1991, Ch 10
   Google Scholar
• Berntzen H B, Olmez U, Fagerhol M K, Munthe E. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthriti. Scand J Rheumatol 1991; 20: 74–82
   PubMed Web of Science ®Google Scholar
• Sander J, Fagerhol M K, Bakken J S, Dale I. Plasma levels of the leukocyte L1 protein in febrile conditions: relation to aetiology, number of leukocytes in blood, blood sedimentation reaction and C-reactive protei. Scand J Clin Lab Invest 1984; 44: 357–362
   PubMed Web of Science ®Google Scholar
• Golden B E, Clohessy P A, Russell G, Fagerhol M K. Calprotectin as a marker of inflammation in cystic fibrosi. Arch Dis Child 1995; 74: 136–137
   Google Scholar
• Young D W. The antineutrophil antibody in uveiti. Br J Ophthalmol 1991; 75: 208–211
   PubMedGoogle Scholar
• Young D W, Dring S, Thompson R. Anti-neutrophil cytoplasmic antibodies in uveitis. Curr Eye Res 1990; 9(Suppl)41–44
   PubMedGoogle Scholar
• Lock R J. Detection of autoantibodies to neutrophil cytoplasmic antigen. J Clin Pathol 1994; 47: 4–8, ACP Broadsheet No 143: January 1994.
   PubMed Web of Science ®Google Scholar
• Soukiasian S H, Foster C S, Niles J L, Raizman M B. Diagnostic value of antineutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosi. Ophthalmology 1992; 99: 125–132
   PubMedGoogle Scholar
• Pulido J S, Goeken J A, Nerad J A, Sobol W M, Folberg R. Ocular manifestations of patients with circulating antineutrophil cytoplasmic antibodie. Arch Ophthalmol 1990; 108: 845–850
   PubMedGoogle Scholar
• de Keizer R J, van der Woude F J. cANCA test and the detection of Wegener's disease in sclerokeratitis and uveitis. Curr Eye Res 1990; 9(Suppl)59–61
   PubMedGoogle Scholar
• Gross W L, Schmitt W H, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspect. Clin Exp Immunnol 1993; 91: 1–12
   PubMed Web of Science ®Google Scholar
• Hagen E C, van de Vijver-Reenalda H, de Keizer R J, et al. Uveitis and antineutrophil cytoplasmic antibodie. Clin Exp Immunol 1994; 95: 56–59
   PubMedGoogle Scholar
• Roseth A G, Fagerhol M K, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in faece. Scand J Gastroenterol 1992; 27: 793–798
   PubMed Web of Science ®Google Scholar
• Wilk A. Delineation of a standard procedure for direct immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989; 97(S6)12–14
   Google Scholar
• Forrester J V. Uveitis pathogenesi. Lancet 1991; 338: 1498–1501
   PubMed Web of Science ®Google Scholar
• Forrester J V, Stott D, Hercus K. Naturally occurring antibodies to bovine and human retinal S-Ag. A comparison between uveitis patients and healthy control. Br J Ophthalmol 1989; 73: 155–159
   PubMed Web of Science ®Google Scholar
• Gregerson D S, Abrahams I W, Thurkill C E. Serum antibody levels of uveitis patients to bovine retinal antigen. Invest Ophthalmol Vis Sci 1981; 21: 669–680
   PubMed Web of Science ®Google Scholar
• deSmet M D, Yakamoto J H, Ger I, Singh V K, Shinohara T, et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragment. Am J Ophthalmol 1990; 110: 135–142
   PubMedGoogle Scholar
• Edelsten C, D'Cruz D, Hughes G R, Graham E M. Anti-endothelial cell antibodies in retinal vasculitis. Curr Eye Res 1992; 11(Suppl)203–208
   PubMedGoogle Scholar
• Zaman A G, Edelsten C, Mason J A, et al. Circulating VCAM-1 is raised in patients with isolated idiopathic retinal vasculiti. Regional Immunol 1994; 6: 64–68
   Google Scholar
• Herbert C P, Okumura A, Mochizuki M. Endotoxin-induced uveitis in the rat. A study of the role of inflammation mediator. Graefe's Arch Clin Exp Ophthalmol 1988; 226: 553–558
   PubMedGoogle Scholar
• Clohessy P A, Golden B E. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defenc. Scand J Immunol 1995; 42: 551–556
   PubMed Web of Science ®Google Scholar
• Radke L L, Hahn B L, Wagner D K, Sohnle P G. Comparison of the metal-binding anti-candidial activities of serum and abscess fluid supernatant. J Med Vet Mycol 1994; 32: 295–301
   PubMedGoogle Scholar
• Murao S, Collart F, Huberman E. A protein complex expressed during terminal differentiation of non-myelocytic cells is an inhibitor of cell growt. Cell Growth Differentiation 1990; 1: 447–454
   PubMedGoogle Scholar
• Kallenberg C GM, Cohen Tervaert J W, van der Woude F J, Gold-Schmeding R, von dem Borne A EGKr, Weening J J. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis?. Immunol Today 1991; 12: 61–64
   PubMedGoogle Scholar